Onconova Therapeutics Inc ONTX Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	39.37M	35.06M	30.47M	27.04M	22.68M	18.17M	18.69M	8.94M
Total Current Assets	39.35M	35.04M	30.45M	27.01M	22.66M	18.15M	18.67M	8.92M
Cash and Equivalents	38.76M	34.22M	29.73M	25.24M	20.82M	16.39M	16.89M	5.41M
Total Non-Current Assets	49k	43k	35k	53k	45k	37k	29k	25k
Total Liabilities	11.06M	12.19M	11.57M	12.52M	12.01M	12.16M	12.59M	10.97M
Total Current Liabilities	8.05M	9.22M	8.67M	9.67M	9.22M	9.42M	9.91M	8.35M
Total Non-Current Liabilities	3.02M	2.96M	2.9M	2.85M	2.79M	2.74M	2.68M	2.62M
Common Equity	209k	210k	210k	210k	210k	211k	253k	30k
Retained Earnings	-463.68M	-469.46M	-473.71M	-478.45M	-482.63M	-487.61M	-610.76M	-619.23M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	23.23M	4.98M	17.92M	23.67M	19.99M	55.48M	39.37M	22.68M
Total Current Assets	23.07M	4.9M	17.77M	23.47M	19.78M	55.43M	39.35M	22.66M
Cash and Equivalents	21.4M	4.02M	16.97M	22.73M	19.03M	55.07M	38.76M	20.82M
Total Non-Current Assets	5.13M	-10.86M	5.39M	11.57M	6.18M	46.12M	28.31M	10.67M
Total Liabilities	18.11M	15.84M	12.54M	12.1M	13.81M	9.36M	11.06M	12.01M
Total Current Liabilities	10.16M	9.98M	8.44M	8.29M	10.02M	6.12M	8.05M	9.22M
Total Non-Current Liabilities	7.95M	5.86M	4.1M	3.81M	3.79M	3.24M	3.02M	2.79M
Total Equity	5.13M	-10.86M	5.39M	11.57M	6.18M	46.12M	28.31M	10.67M
Common Equity	68k	108k	57k	1.11M	1.86M	209k	209k	210k
Retained Earnings	-338.22M	-362.32M	-381.9M	-403.4M	-428.56M	-444.72M	-463.68M	-482.63M